Neuralieve is a medical technology company that is pursuing a completely new approach to
the treatment of migraine headache. Our core technology is based on the science of transcranial magnetic stimulation (TMS), a modality that has been used extensively in brain research. In studying TMS for the treatment of headache, we believe we are breaking new ground in non-drug, non-behavioral therapy for migraine. We think that TMS has the potential to become a highly effective option for patients who need relief beyond that provided by today’s widely used pharmacologic agents and to offer patients a safe, effective alternative to existing drug therapy.
Caution: Investigational Use Only
Join our mailing list for periodic updates from Neuralieve
Print a Company Backgrounder (PDF)